COMP <GO>
ECG vs V // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Everus Construction Group Inc. (NYSE) VS. Visa Inc. (NYSE) • 15-METRIC TALLY: ECG 4
— V 11
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: V
LAST: $102.63 (-5.02%) • MKT CAP: $5.52B
options-implied-move
7.30%
LAST: $413.59 (+0.74%) • MKT CAP: $733.53B
options-implied-move
7.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ECG VS. V)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ECG | V | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 12.10% | 41.00% | -28.90 | V | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 30.40% | 32.30% | -1.90 | V | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.7x | 28.9x | -15.20 | ECG | /valuation <GO> |
| Free Cash Flow Yield | -0.21% | 2.90% | -3.11 | V | /fcf-yield <GO> |
| Operating Margin | 7.10% | 60.00% | -52.90 | V | /operating-margins <GO> |
| Net Profit Margin | 5.40% | 50.10% | -44.70 | V | /net-margins <GO> |
| Revenue Growth (YoY) | 31.50% | 11.30% | +20.20 | ECG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.63% | -0.63 | V | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.47 | 9.09 | -2.62 | V | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 9/9 | -3.00 | V | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 7.30% | 7.10% | +0.20 | V | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 40.3 | 69.4 | -29.13 | V | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.13 | 1.06 | +0.07 | ECG | /macro-sensitivity <GO> |
| Forward P/E Multiple | 22.9x | 34.0x | -11.10 | ECG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.52B | $733.53B | -$728.02B | V | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ECG REV | V REV | ECG GROSS % | V GROSS % | ECG FCF | V FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.75B | $40.00B | 12.1% | 44.0% | -$11.7M | $21.26B |
| FY 2024 | $2.85B | $35.93B | 11.9% | 44.0% | $35.1M | $18.33B |
| FY 2023 | $2.85B | $32.65B | 44.0% | 44.0% | $42.9M | $19.29B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ECG // BETA 1.13
V // BETA 1.06